Status:

COMPLETED

Is Milk Associated with Glycemia in the NICU

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Premature Birth

Eligibility:

All Genders

Up to 3 years

Brief Summary

The purpose of this study is to determine if concentrations of hormones in prepared human milk (HM) feeds are associated with metabolic disturbances in the recipient premature infant. To do so, prospe...

Detailed Description

The purpose of this study is to determine if concentrations of these hormones in prepared HM feeds are associated with metabolic disturbances in the recipient infant. A prospectively study 100 infants...

Eligibility Criteria

Inclusion

  • Infants eligible to receive human milk (HM)-derived fortifiers. To qualify for these fortifiers, infants must be born \<30 weeks gestation and/or weigh \<1250g at birth. Enteral or oral feeding modes both qualify for participation. Additional supplementation to feeds beyond HM-derived fortifier (such as medium-chain triglycerides) is acceptable.
  • Infants initially on intravenous nutrition will still be eligible for consent. Feed sample collections from these infants will commence once they advance to consume HM-based feeds once HM-derived fortifier is prescribed.

Exclusion

  • Infants diagnosed with congenital disorders that impact glucose or calcium metabolism will be excluded.
  • Infants with conditions necessitating specialized diets (ex: chylothorax) will also be excluded.
  • Non-English speaking subjects will be excluded as the team of study personnel includes those that speak English only.

Key Trial Info

Start Date :

February 16 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 10 2024

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT05256927

Start Date

February 16 2022

End Date

March 10 2024

Last Update

March 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester Medical Center

Rochester, New York, United States, 14642